These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22220585)
1. Personality differences between drug injectors and non-injectors among substance-dependent patients in substitution treatment. Saint-Lèbes J; Rodgers R; Birmes P; Schmitt L Am J Drug Alcohol Abuse; 2012 Mar; 38(2):135-9. PubMed ID: 22220585 [TBL] [Abstract][Full Text] [Related]
2. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia. Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093 [TBL] [Abstract][Full Text] [Related]
3. The relationship of suicide attempt history with childhood abuse and neglect, alexithymia and temperament and character dimensions of personality in substance dependents. Evren C; Evren B Nord J Psychiatry; 2006; 60(4):263-9. PubMed ID: 16923633 [TBL] [Abstract][Full Text] [Related]
5. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia. Winstock AR; Lea T Subst Use Misuse; 2010; 45(1-2):240-52. PubMed ID: 20025451 [TBL] [Abstract][Full Text] [Related]
6. Early experience with Suboxone maintenance therapy in Hungary. Demetrovics Z; Farkas J; Csorba J; Németh A; Mervó B; Szemelyácz J; Fleischmann E; Kassai-Farkas A; Petke Z; Oroján T; Rózsa S; Rigó P; Funk S; Kapitány M; Kollár A; Rácz J Neuropsychopharmacol Hung; 2009 Dec; 11(4):249-57. PubMed ID: 20150662 [TBL] [Abstract][Full Text] [Related]
7. [Character and temperament dimensions of patients with temporomandibular disorder]. Darcan A; Onur E; Köse T; Alkin T; Erdem A Turk Psikiyatri Derg; 2008; 19(3):274-82. PubMed ID: 18791880 [TBL] [Abstract][Full Text] [Related]
8. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone. Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786 [TBL] [Abstract][Full Text] [Related]
9. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Madden A; Lea T; Bath N; Winstock AR Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Winstock AR; Lea T; Sheridan J Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216 [TBL] [Abstract][Full Text] [Related]
11. [The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements]. Håkansson AC Lakartidningen; 2012 Jun 19-26; 109(25):1216-7. PubMed ID: 22838110 [No Abstract] [Full Text] [Related]
12. Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients. Raby WN; Carpenter KM; Aharonovich E; Rubin E; Bisaga A; Levin F; Nunes EV Drug Alcohol Depend; 2006 Feb; 81(3):283-92. PubMed ID: 16182468 [TBL] [Abstract][Full Text] [Related]
13. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758 [TBL] [Abstract][Full Text] [Related]
14. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction]. Thirion X; Barrau K; Micallef J; Haramburu F; Lowenstein W; Sanmarco JL Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372 [TBL] [Abstract][Full Text] [Related]
15. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005 [TBL] [Abstract][Full Text] [Related]
16. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Giacomuzzi S; Kemmler G; Ertl M; Riemer Y Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744 [TBL] [Abstract][Full Text] [Related]
17. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger]. Pelissolo A; Corruble E Encephale; 2002; 28(4):363-73. PubMed ID: 12232546 [TBL] [Abstract][Full Text] [Related]
18. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Darke S; Hetherington K; Ross J; Lynskey M; Teesson M Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024 [TBL] [Abstract][Full Text] [Related]
19. [Epilepsy and personality study among the Tamberma of Togo based on a general population survey using the Cloninger's Temperament and Character Inventory]. Nubukpo P; Grunitzky EK; Pélissolo A; Radji A; Preux PM; Clément JP Encephale; 2006; 32(6 Pt 1):1019-22. PubMed ID: 17378087 [TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence. Lavie E; Fatséas M; Denis C; Auriacombe M Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]